DOCSLIB.ORG

Neuroprotective Sirtuin Ratio Reversed by Apoe4

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neuroprotective Sirtuin Ratio Reversed by Apoe4 Neuroprotective Sirtuin ratio reversed by ApoE4 Veena Theendakaraa,1, Alexander Patenta,1, Clare A. Peters Libeua, Brittany Philpota, Sonia Floresa, Olivier Descampsa, Karen S. Poksaya, Qiang Zhanga, Gabriellee Cailinga, Matthew Hartb, Varghese Johna, Rammohan V. Raoa,2,3, and Dale E. Bredesena,c,2,3 aThe Buck Institute for Research on Aging, Novato, CA 94945; bDepartment of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX 78245; and cDepartment of Neurology, University of California, San Francisco, CA 94143 Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved September 26, 2013 (received for review July 26, 2013) The canonical pathogenesis of Alzheimer’s disease links the ex- In contrast, cleavage at the α site produces the trophic peptide pression of apolipoprotein E e4 allele (ApoE) to amyloid precursor sAPPα and the inhibitor of APP γ-site cleavage, alpha-COOH- protein (APP) processing and Aβ peptide accumulation by a set of terminal fragment of APP (αCTF) (1, 6). The decision between mechanisms that is incompletely defined. The development of these two proteolytic pathways is governed at least in part by a simple system that focuses not on a single variable but on mul- ligand binding: interaction with the axon guidance and trophic tiple factors and pathways would be valuable both for dissecting factor netrin-1 increases α-site cleavage, whereas interaction with the underlying mechanisms and for identifying candidate thera- the antitrophin Aβ inhibits α-site cleavage and increases net pro- peutics. Here we show that, although both ApoE3 and ApoE4 duction of the four neurite-retractive peptides (1, 6). According associate with APP with nanomolar affinities, only ApoE4 signifi- to a recent study, the level of cerebrospinal fluid (CSF) sAPPα is cantly (i) reduces the ratio of soluble amyloid precursor protein significantly lower in AD patients possessing one or two ApoE4 alpha (sAPPα)toAβ;(ii) reduces Sirtuin T1 (SirT1) expression, alleles than in those not possessing the ApoE4 allele (7). There- resulting in markedly differing ratios of neuroprotective SirT1 to fore, it was of interest to determine whether ApoE isoforms im- neurotoxic SirT2; (iii) triggers Tau phosphorylation and APP phos- pact this trophic–antitrophic peptide balance differentially, and, if phorylation; and (iv) induces programmed cell death. We describe so, by what mechanism. a subset of drug candidates that interferes with the APP–ApoE Our data reveal differential effects of ApoE4 vs. ApoE3 on interaction and returns the parameters noted above to normal. APP interaction, signaling, and processing and are compatible NEUROSCIENCE Our data support the hypothesis that neuronal connectivity, as with the notion that the Alzheimer’s phenotype represents an reflected in the ratios of critical mediators such as sAPPα:Aβ, imbalance between the trophic and antitrophic signaling of APP, SirT1:SirT2, APP:phosphorylated (p)-APP, and Tau:p-Tau, is pro- reflected by the ratio of the four APP-derived neurite-retractive grammatically altered by ApoE4 and offer a simple system peptides to the two APP-derived trophic peptides. Our current for the identification of program mediators and therapeutic results show that ApoE4 interacts with high affinity with APP, candidates. shifting the processing balance in the antitrophic direction, de- creasing sAPPα secretion, and reducing sAPPα/Aβ and sAPPα/ lzheimer’s disease (AD) poses a health problem of pan- sAPPβ ratios in comparison with ApoE3. In addition, the pres- Ademic proportions. It is estimated that by the year 2030 ence of ApoE4 results in increased APP-Thr668 phosphorylation there will be greater than 60 million people worldwide with AD, (p-APP) and Tau phosphorylation (p-Tau). Some of these and $375 billion will be spent annually in the United States to ApoE4-mediated events were blocked by proteasomal inhibitors, care for affected individuals. The tedious and expensive process and in a small pilot study, the proteasomal inhibitor disulfiram of drug discovery in AD is complicated by the fact that the causes and a CDK inhibitor were shown to be effective in reversing and underlying mechanisms of the disease are still incompletely some of the ApoE4-mediated effects. Furthermore, we identified defined, and presymptomatic diagnosis is not yet in routine clinical use (1). Significance The apolipoprotein E e4 allele (ApoE; chromosomal locus 19q13) is the single most important genetic risk factor associated This manuscript links ApoE4-mediated signaling with Sirtuin with AD. This allele confers increased risk for sporadic and fa- function. Specifically, we show that ApoE4, but not ApoE3, milial AD (2). Individuals with two copies of the ApoE e4 allele reduces neuroprotective SirT1 levels. Our data support the hy- have an approximately eightfold increased risk of AD and have fi pothesis that neuronal connectivity, as reflected in the ratios of a signi cantly lower age of onset compared with AD patients not α β carrying this allele (2). Recent data indicate that the greater risk critical mediators such as sAPP :A , SirT1:SirT2, APP:p-APP, and of AD associated with the ApoE4 isoform might relate to ApoE’s Tau:p-Tau, is programmatically altered by ApoE4. Thus ApoE4, susceptibility to proteolysis and neurotoxicity or through its role SirT1/2, p-Tau, and p-APP, all may be part of a signaling network in inhibiting Aβ clearance and/or stimulating Aβ deposition, that is affected in AD, providing a model for therapeutic candi- leading to plaque formation (3, 4). Contrary to the previously date screening in AD drug discovery. These findings offer a reported work, one recent study provides evidence that ApoE and unique insight into the mechanism by which ApoE4 confers risk soluble Aβ have very minimal direct interaction, thus ApoE may for the development of Alzheimer’s disease. influence soluble Aβ metabolism through its interactions with other receptors or transporters (5). Thus, despite knowing for Author contributions: R.V.R. and D.E.B. designed research; V.T., A.P., C.A.P.L., B.P., S.F., over a decade that the ApoE e4 allele is somehow contributory to O.D., K.S.P., Q.Z., G.C., M.H., and R.V.R. performed research; V.J., R.V.R., and D.E.B. ana- lyzed data; and R.V.R. and D.E.B. wrote the paper. the disease process, the precise molecular mechanisms underlying fl ApoE and APP interactions, direct or indirect, resulting in The authors declare no con ict of interest. ApoE4-mediated toxicity, remain unclear. This article is a PNAS Direct Submission. The amyloid precursor protein, APP, has been shown to 1V.T. and A.P. contributed equally to this work. function as a molecular switch: cleavage at the β, γ, and caspase 2R.V.R. and D.E.B. contributed equally to this work. — 3 sites results in the production of four pro-AD-peptides soluble To whom correspondence may be addressed. E-mail: [email protected] or amyloid precursor protein beta (sAPPβ) (from which N-APP is [email protected]. derived), Aβ, Jcasp, and C31—that mediate neurite retraction, This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. synaptic reorganization, and ultimately programmed cell death. 1073/pnas.1314145110/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1314145110 PNAS Early Edition | 1of6 Downloaded by guest on October 1, 2021 initial therapeutic candidates—F03 and F05—that normalize some ApoE4 Binds to APP at Endocytic pH with a Significantly Higher of the ApoE4 effects. Affinity than ApoE3. We also confirmed the interaction of ApoE In addition to these effects on APP processing and signaling, and APP by surface plasmon resonance (SPR) to measure the ApoE4 expression was associated with a marked reduction in the binding of recombinant ApoE isoforms with recombinant pro- ratio of SirT1 to SirT2, both in cultured neural cells and in the tein fragments of the ectodomain of APP, as well as the full brains of patients with AD. Because SirT1 has been implicated in ectodomain of APP695 (eAPP19–624) at pHs more characteristic neuroprotection and SirT2 in neurodegeneration (8), this effect of intracellular compartments. Analysis of the recombinant of ApoE4 may be important from both mechanistic and thera- ApoE with a calibrated Superdex S-200 size-exclusion chroma- peutic development standpoints. tography column gave the expected molecular weight of the Our data support the view that ApoE4 modulates the con- ApoE tetramer for both ApoE3 and ApoE4, indicating that nectivity balance, as reflected in the ratios of sAPPα:sAPPβ, the amounts of lipid retained were small in comparison with the sAPPα:Aβ, SirT1:SirT2, APP:p-APP, and Tau:p-Tau. The net- mass of the protein. The E2 domain of APP and the Aβ-cognate work of proteins that mediates this balance thus represents a set region (trx-eAPP290–624) gave an effective KD of 80 nM for A B of candidate targets for the prevention and treatment of ApoE4- ApoE4 and 300 nM for ApoE3 (Fig. 2 and , Table S1, and associated processes such as mild cognitive impairment and AD. Fig. S3). Although both ApoE and APP self-associate (10), the amount of ApoE–APP complex formed at equilibrium approxi- Results mated the isotherm expected for a single-binding equilibrium C D ApoE Isoforms Associate with APP. Although the lipidation status (Fig. 2 and ), consistent with previous observations regarding of ApoE affects its structure (9), it is not yet clear whether the the association of ApoE-containing VLDL particles at pH risk associated with ApoE4 is related solely to lipidated ApoE4, greater than 7 (11). At pH 6.5, we found a consistent trend that ApoE4 displayed tighter binding than ApoE3 independent of to poorly lipidated ApoE4, to unlipidated ApoE4, or to a com- whether the ApoE or APP was attached to the flow cell surface.
Load more

Recommended publications
  • Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence
    International Journal of Molecular Sciences Article Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence Noemi Sola-Sevilla 1, Ana Ricobaraza 2, Ruben Hernandez-Alcoceba 2 , Maria S. Aymerich 3,4, Rosa M. Tordera 1 and Elena Puerta 1,* 1 Pharmacology and Toxicology Department, Faculty of Pharmacy, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (N.S.-S.); [email protected] (R.M.T.) 2 Gene Therapy Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (A.R.); [email protected] (R.H.-A.) 3 Departamento de Bioquímica y Genética, Facultad de Ciencias, Universidad de Navarra, 31008 Pamplona, Spain; [email protected] 4 Neuroscience Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain * Correspondence: [email protected] Abstract: Sirtuin 2 (SIRT2) has been associated to aging and age-related pathologies. Specifically, an age-dependent accumulation of isoform 3 of SIRT2 in the CNS has been demonstrated; however, no study has addressed the behavioral or molecular consequences that this could have on aging. In the present study, we have designed an adeno-associated virus vector (AAV-CAG-Sirt2.3-eGFP) for the overexpression of SIRT2.3 in the hippocampus of 2 month-old SAMR1 and SAMP8 mice. Our Citation: Sola-Sevilla, N.; results show that the specific overexpression of this isoform does not induce significant behavioral or Ricobaraza, A.; Hernandez-Alcoceba, molecular effects at short or long term in the control strain. Only a tendency towards a worsening in R.; Aymerich, M.S.; Tordera, R.M.; the performance in acquisition phase of the Morris Water Maze was found in SAMP8 mice, together Puerta, E.
    [Show full text]
  • The Role of Sirtuin 2 Activation by Nicotinamide Phosphoribosyltransferase in the Aberrant Proliferation and Survival of Myeloid Leukemia Cells
    Acute Myeloid Leukemia Articles and Brief Reports The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells Lan Dan, 1,4 Olga Klimenkova, 1 Maxim Klimiankou, 1 Jan-Henning Klusman, 2 Marry M. van den Heuvel-Eibrink, 3 Dirk Reinhardt, 2 Karl Welte, 1 and Julia Skokowa 1 1Department of Molecular Hematopoiesis, Children’s Hospital, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Hematology and Oncology, Children’s Hospital, Hannover Medical School, Hannover, Germany; and 3Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; 4Department of Pediatrics, The First Affiliated Hospital of GuangXi Medical University, NanNing, China ABSTRACT Acknowledgments: we thank Background A. Gigina, A. Müller Brechlin Inhibitors of nicotinamide phosphoribosyltransferase have recently been validated as therapeu - and M. Reuter for their excellent tic targets in leukemia, but the mechanism of leukemogenic transformation downstream of this technical assistance. enzyme is unclear. Manuscript received on Design and Methods September 14, 2011. Revised version arrived on November 21, Here, we evaluated whether nicotinamide phosphoribosyltransferase’s effects on aberrant pro - 2011. Manuscript accepted liferation and survival of myeloid leukemic cells are dependent on sirtuin and delineated the on December 19, 2011. downstream signaling pathways operating during this process. Correspondence: Results Karl Welte, Department of We identified significant upregulation of sirtuin 2 and nicotinamide phosphoribosyltransferase Molecular Hematopoiesis, Hannover levels in primary acute myeloid leukemia blasts compared to in hematopoietic progenitor cells Medical School, Carl-Neuberg from healthy individuals. Importantly, specific inhibition of nicotinamide phosphoribosyltrans - Str. 1, 30625 Hannover, ferase or sirtuin 2 significantly reduced proliferation and induced apoptosis in human acute Germany.
    [Show full text]
  • The Sirtuin Family's Role in Aging and Age-Associated Pathologies
    The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, … , Yoonjin Lee, Pere Puigserver J Clin Invest. 2013;123(3):973-979. https://doi.org/10.1172/JCI64094. Review Series The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neurodegeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age- related decline. Here we review experimental evidence both for and against this proposal, as well as the implications that isoform-specific sirtuin activation may have for healthy aging in humans. Find the latest version: https://jci.me/64094/pdf Review series The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, John E. Dominy, Yoonjin Lee, and Pere Puigserver Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA. The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neuro- degeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age-related decline.
    [Show full text]
  • Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
    H OH metabolites OH Review Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer Mio Harachi 1, Kenta Masui 1,* , Webster K. Cavenee 2, Paul S. Mischel 3 and Noriyuki Shibata 1 1 Department of Pathology, Division of Pathological Neuroscience, Tokyo Women’s Medical University, Tokyo 162-8666, Japan; [email protected] (M.H.); [email protected] (N.S.) 2 Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA 92093, USA; [email protected] 3 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; [email protected] * Correspondence: [email protected]; Tel.: +81-3-3353-8111; Fax: +81-3-5269-7408 Abstract: Metabolic reprogramming is an emerging hallmark of cancer and is driven by abnormalities of oncogenes and tumor suppressors. Accelerated metabolism causes cancer cell aggression through the dysregulation of rate-limiting metabolic enzymes as well as by facilitating the production of intermediary metabolites. However, the mechanisms by which a shift in the metabolic landscape reshapes the intracellular signaling to promote the survival of cancer cells remain to be clarified. Recent high-resolution mass spectrometry-based proteomic analyses have spotlighted that, unex- pectedly, lysine residues of numerous cytosolic as well as nuclear proteins are acetylated and that this modification modulates protein activity, sublocalization and stability, with profound impact on cellular function. More importantly, cancer cells exploit acetylation as a post-translational protein for microenvironmental adaptation, nominating it as a means for dynamic modulation of the phenotypes of cancer cells at the interface between genetics and environments.
    [Show full text]
  • And Sirtuin 2 (SIRT2) in Inhibiting Cargo- Loading and Release of Extracellular Vesicles Byung Rho Lee, Bethany J
    www.nature.com/scientificreports OPEN Distinct role of Sirtuin 1 (SIRT1) and Sirtuin 2 (SIRT2) in inhibiting cargo- loading and release of extracellular vesicles Byung Rho Lee, Bethany J. Sanstrum, Yutao Liu & Sang-Ho Kwon * Exosomes, vehicles for intercellular communication, are formed intracellularly within multivesicular bodies (MVBs) and are released upon fusion with the plasma membrane. For their biogenesis, proper cargo loading to exosomes and vesicle trafc for extracellular release are required. Previously we showed that the L-type lectin, LMAN2, limits trans-Golgi Network (TGN)-to-endosomes trafc of GPRC5B, an exosome cargo protein, for exosome release. Here, we identifed that the protein deacetylase sirtuin 2 (SIRT2) as a novel interactor of LMAN2. Loss of SIRT2 expression resulted in exosomal release of LMAN2, a Golgi resident protein, along with increased exosomal release of GPRC5B. Furthermore, knockout of SIRT2 increased total number of extracellular vesicles (EVs), indicating increased MVB-to-EV fux. While knockout of SIRT1 increased EV release with enlarged late endolysosome, knockout of SIRT2 did not exhibit endolysosome enlargement for increased EV release. Taken together, our study suggests that SIRT2 regulates cargo loading to MVBs and MVB-to-EV fux through a mechanism distinct from that of SIRT1. Small extracellular vesicles (EVs) called exosomes are vehicles for intercellular communication1,2 and are involved in the progression of many human disease or protection against diseases3,4. Cargoes loaded in exosomes can range from various RNAs to growth factors and extracellular remodeling molecules3,5–7. For the communication role, select cargo loading and proper vesicle trafcking in exosome producing cells as well as retrieval of exosomes to target cells are required.
    [Show full text]
  • A Novel Sirtuin 2 (SIRT2) Inhibitor with P53-Dependent Pro-Apoptotic
    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 289, NO. 8, pp. 5208–5216, February 21, 2014 © 2014 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer*□S Received for publication, August 19, 2013, and in revised form, December 17, 2013 Published, JBC Papers in Press, December 30, 2013, DOI 10.1074/jbc.M113.487736 Gesine Hoffmann‡**, Frank Breitenbücher§, Martin Schuler§¶, and Ann E. Ehrenhofer-Murray‡**1 From the ‡Zentrum fu¨r Medizinische Biotechnologie, Universität Duisburg-Essen, 45117 Essen, Germany, the §Innere Klinik (Tumorforschung), Westdeutsches Tumorzentrum, Universitätsklinikum Essen, 45147 Essen, Germany, the ¶German Cancer Consortium (DKTK) , 69120 Heidelberg, Germany, and the **Humboldt-Universität zu Berlin, Institut fu¨r Biologie, Abteilung Molekulare Zellbiologie, 10115 Berlin, Germany Background: Pharmacological inhibition of the NADϩ-dependent deacetylase SIRT2 holds promise for cancer therapy by preventing deacetylation and inactivation of p53. Results: We identified two novel SIRT2 inhibitors that induce apoptosis in a p53-dependent fashion and activate three p53 target genes. Conclusion: Small-molecule inhibition of SIRT2 activates p53-dependent apoptosis in cancer cells. Significance: The compounds reported here are promising lead candidates for use in cancer treatment. ؉ Sirtuin 2 (SIRT2) is an NAD -dependent protein deacetylase activity (3–5). Sirtuin enzymes have received widespread atten- whose targets include histone H4 lysine 16, p53, and ␣-tubulin. tion over the last few years due to their diverse physiological Because deacetylation of p53 regulates its effect on apoptosis, roles in metabolism, aging, and age-related human disorders pharmacological inhibition of SIRT2-dependent p53 deacetyla- (6–8).
    [Show full text]
  • Sirtuin 2 Dysregulates Autophagy in High-Fat-Exposed Immune-Tolerant Macrophages
    cells Article Sirtuin 2 Dysregulates Autophagy in High-Fat-Exposed Immune-Tolerant Macrophages Sanjoy Roychowdhury 1,†, Anugraha Gandhirajan 1,†, Christopher Kibler 1, Xianfeng Wang 2 and Vidula Vachharajani 1,3,* 1 Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, OH 44195, USA; [email protected] (S.R.); [email protected] (A.G.); [email protected] (C.K.) 2 Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA; [email protected] 3 Department of Critical Care, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA * Correspondence: [email protected] † These authors contributed equally to the manuscript and should be considered co-1st authors. Simple Summary: SIRT2 regulates autophagy in high-fat-exposed immune cells. Abstract: Obesity increases morbidity and resource utilization in sepsis patients. The immune response in sepsis transitions from an endotoxin-responsive hyper- to an endotoxin-tolerant hypo- inflammatory phase. The majority of sepsis mortality occurs during hypo-inflammation. We reported prolonged hypo-inflammation with increased sirtuin 2 (SIRT2) expression in obese-septic mice. The effect of direct exposure to high-fat/free fatty acid (FFA) and the role of SIRT2 in immune cells during the transition to hypo-inflammation is not well-understood. Autophagy, a degradation process of damaged protein/organelles, is dysregulated during sepsis. Here, we investigated the effect of direct FFA exposure and the role of SIRT2 expression on autophagy as macrophages transition from Citation: Roychowdhury, S.; hyper-to hypo-inflammation. We found, FFA-exposed RAW 264.7 cells with lipopolysaccharide Gandhirajan, A.; Kibler, C.; Wang, X.; (LPS) stimulation undergo endotoxin-sensitive (“sensitive”) hyper- followed by endotoxin tolerant Vachharajani, V.
    [Show full text]
  • Active Sirtuin 2 (SIRT2), Human Recombinant
    For research use only BioVision rev 08/21 Active Sirtuin 2 (SIRT2), Human Recombinant UNIT DEFINITION: One unit of the recombinant SIRT2 is defined as the amount of enzyme that deacetylates 1 µmol of substrate Arg-His-Lys-Lys(Ac)-AFC per minute at 37 °C under the CATALOG #: 7698-10 10 µg assay conditions using BiovVision’s Sirtuin Activity Assay Kit (Fluorometric) (Cat. No. K324). 7698-50 50 µg 7698-1000 1 mg ALTERNATE NAMES: NAD-dependent protein deacetylase sirtuin-2, Regulatory protein SIR2 homolog 2, SIR2-like protein 2, SIR2L, SIR2L2. SOURCE: E. coli PURITY: ≥ 90 % by SDS-PAGE SDS-PAGE analysis of human Sirtuin 2 protein SPECIFIC ACTIVITY: ≥ 0.5 mU/mg Lane 1: Marker. Lane 2: 5 µg of protein is loaded on the gel and stained MOLECULAR WEIGHT: 60 kDa (2 to 389 aa + N-terminal His and Trx Tag) with Coomassie Blue. FORM: Sirtuin 2 (SIRT2) with a His-tag is supplied as lyophilized powder. FORMULATION: Human Sirtuin 2 is lyophilized from 50 mM Tris, pH 8.0. STORAGE CONDITIONS: Stable for 1 year at –20 °C. RECONSTITUTION: Centrifuge the vial prior to opening. Reconstitute in 25 mM Tris, pH 7.5, 100 mM NaCl, 2.7 mM KCl, 3 mM MgCl2 and 35% Glycerol to a concentration of 0.1 – 1 mg/ml and let the lyophilized pellet dissolve completely. This solution can then be stored at –20 °C for future use. For long term storage, it is recommended to add a carrier protein (0.1% BSA) in above reconstitution solution. Avoid multiple freeze/thaw cycles.
    [Show full text]
  • Sirtuin 2 Regulates Cellular Iron Homeostasis Via Deacetylation of Transcription Factor NRF2
    The Journal of Clinical Investigation RESEARCH ARTICLE Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2 Xiaoyan Yang,1 Seong-Hoon Park,2,3 Hsiang-Chun Chang,1 Jason S. Shapiro,1 Athanassios Vassilopoulos,2 Konrad T. Sawicki,1 Chunlei Chen,1 Meng Shang,1 Paul W. Burridge,4 Conrad L. Epting,5 Lisa D. Wilsbacher,1 Supak Jenkitkasemwong,6 Mitchell Knutson,6 David Gius,2 and Hossein Ardehali1 1Feinberg Cardiovascular Research Institute and 2Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 3Department of General and Applied Toxicology, Innovative Toxicology Research Center, Korea Institute of Toxicology (KIT), Daejeon, South Korea. 4Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 5Departments of Pediatrics and Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 6Food Science and Human Nutrition Department, University of Florida, Gainesville, Florida, USA. SIRT2 is a cytoplasmic sirtuin that plays a role in various cellular processes, including tumorigenesis, metabolism, and inflammation. Since these processes require iron, we hypothesized that SIRT2 directly regulates cellular iron homeostasis. Here, we have demonstrated that SIRT2 depletion results in a decrease in cellular iron levels both in vitro and in vivo. Mechanistically, we determined that SIRT2 maintains cellular iron levels by binding to and deacetylating nuclear factor erythroid-derived 2–related factor 2 (NRF2) on lysines 506 and 508, leading to a reduction in total and nuclear NRF2 levels. The reduction in nuclear NRF2 leads to reduced ferroportin 1 (FPN1) expression, which in turn results in decreased cellular iron export. Finally, we observed that Sirt2 deletion reduced cell viability in response to iron deficiency.
    [Show full text]
  • SIRT2 Directs the Replication Stress Response Through CDK9 Deacetylation
    SIRT2 directs the replication stress response through CDK9 deacetylation Hui Zhanga,1, Seong-Hoon Parkb,1, Brooke G. Pantazidesa, Oleksandra Karpiukc, Matthew D. Warrena,ClaireW.Hardya, Duc M. Duongd, So-Jeong Park e, Hyun-Seok Kim e, Athanassios Vassilopoulos b, Nicholas T. Seyfried d,StevenA.Johnsenc, David Giusb,andDavidS.Yua,2 aDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322; bDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611; cDepartment of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; dDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322; and eDepartment of Life Science, College of Natural Science, Ewha Womans University, Seoul 120-750, Korea Edited by Kevin Struhl, Harvard Medical School, Boston, MA, and approved July 1, 2013 (received for review January 23, 2013) Sirtuin 2 (SIRT2) is a sirtuin family deacetylase that directs acety- instability, and expression of fragile sites of mammalian chro- lome signaling, protects genome integrity, and is a murine tumor mosomes (22). ATR senses stalled replication forks that result suppressor. We show that SIRT2 directs replication stress re- from uncoupling that exposes replication protein A (RPA)- sponses by regulating the activity of cyclin-dependent kinase 9 bound single-stranded DNA (ssDNA) (23). Finally, RSR mobi- (CDK9), a protein required for recovery from replication arrest. lizes several activities necessary to maintain genome integrity, SIRT2 deficiency results in replication stress sensitivity, impairment including arresting the cell cycle, inhibiting the onset of mitosis, in recovery from replication arrest, spontaneous accumulation of stabilizing the stalled replication fork, and facilitating repli- replication protein A to foci and chromatin, and a G2/M checkpoint cation recovery.
    [Show full text]
  • Sirtuins in Alzheimer's Disease: SIRT2-Related Genophenotypes and Implications for Pharmacoepigenetics
    International Journal of Molecular Sciences Article Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics Ramón Cacabelos 1,*, Juan C. Carril 1 , Natalia Cacabelos 1, Aleksey G. Kazantsev 2, Alex V. Vostrov 2, Lola Corzo 1, Pablo Cacabelos 1 and Dmitry Goldgaber 2 1 EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, 15165 Bergondo, Corunna, Spain; [email protected] (J.C.C.); [email protected] (N.C.); [email protected] (L.C.); [email protected] (P.C.) 2 Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY 11794, USA; [email protected] (A.G.K.); [email protected] (A.V.V.); [email protected] (D.G.) * Correspondence: [email protected]; Tel.: +34-981-780-505 Received: 22 February 2019; Accepted: 7 March 2019; Published: 12 March 2019 Abstract: Sirtuins (SIRT1-7) are NAD+-dependent protein deacetylases/ADP ribosyltransferases with important roles in chromatin silencing, cell cycle regulation, cellular differentiation, cellular stress response, metabolism and aging. Sirtuins are components of the epigenetic machinery, which is disturbed in Alzheimer’s disease (AD), contributing to AD pathogenesis. There is an association between the SIRT2-C/T genotype (rs10410544) (50.92%) and AD susceptibility in the APOE#4-negative population (SIRT2-C/C, 34.72%; SIRT2-T/T 14.36%). The integration of SIRT2 and APOE variants in bigenic clusters yields 18 haplotypes. The 5 most frequent bigenic genotypes in AD are 33CT (27.81%), 33CC (21.36%), 34CT (15.29%), 34CC (9.76%) and 33TT (7.18%). There is an accumulation of APOE-3/4 and APOE-4/4 carriers in SIRT2-T/T > SIRT2-C/T > SIRT2-C/C carriers, and also of SIRT2-T/T and SIRT2-C/T carriers in patients who harbor the APOE-4/4 genotype.
    [Show full text]
  • Review Biological and Potential Therapeutic Roles of Sirtuin
    Cell. Mol. Life Sci. 65 (2008) 4000 – 4018 1420-682X/08/244000-19 Cellular and Molecular Life Sciences DOI 10.1007/s00018-008-8357-y Birkhuser Verlag, Basel, 2008 Review Biological and Potential Therapeutic Roles of Sirtuin Deacetylases D. M. Taylora, M. M. Maxwellb, R. Luthi-Cartera, A. G. Kazantsevb, * a Brain Mind Institute, Ecole Polytechnique Fdrale de Lausanne (EPFL), 1015 Lausanne (Switzerland) b Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, 114 16th Street, Charlestown, MA 02129 (USA), Fax: 617-724-1480, e-mail: [email protected] Received 25 June 2008; received after revision 20 August 2008; accepted 29 August 2008 Online First 27 September 2008 Abstract. Sirtuins comprise a unique class of nicoti- mammalian sirtuins in less than a decade. The namide adenine dinucleotide (NAD+)-dependent de- implication of sirtuins in medically important areas acetylases that target multiple protein substrates to such as diabetes, cancer, cardiovascular dysfunction execute diverse biological functions. These enzymes and neurodegenerative disease has further catapulted are key regulators of clinically important cellular and them to a prominent status as potential targets for organismal processes, including metabolism, cell di- nutritional and therapeutic development. Here, we vision and aging. The desire to understand the present a review of published results on sirtuin biology important determinants of human health and lifespan and its relevance to human disease. has resulted in a firestorm of work on the seven Keywords. Sirtuin, deacetylase, longevity, human disease, therapeutics. Introduction lated research has placed a great emphasis on the study of post-translational modification cascades. The biological function of most proteins relies on The post-translational addition of an acetyl moiety to reversible post-translational modification.
    [Show full text]